Study On The Effectiveness Of Asthma Management Based On Smart Phone Asthma Management APP

Objective:To evaluate the effectiveness of the asthma management application(Asthma management application)based on the smartphone for asthma management.Materials and methods:Materials:From May 2017 to October 2017,a total of 30 asthmatic patients in the First Affiliated Hospital of Nanchang University were selected according to the visiting time,inclusion criteria and exclusion criteria.Patients were randomly divided into experimental group(n=15)and control group(n=15).we collectted basic data and clinical data of patients including gender,age,height,symptoms of emergency department visits,asthma test(Asthma control of Test,ACT)score,asthma medication compliance(Medication Adherence Report Scale for Asthma,MARS-A)quality of life score,simplified version(Mini-Asthma Quality of Life Questionnaire,Mini-AQLQ)score,peak expiratory flow(Peak expiratory,flow,PEF),FEV1 percentage of predicted value(Forced expiratory volume in one second/prediction,FEV1%pred),exhaled nitric oxide(Fractional exhaled nitric oxide,Fe-NO).Methods: Patients in control group were managed by traditional asthma management mode,such as keeping an asthma diary,outpatient follow up and Paper version of asthma action plan.During the first month,The third month and The sixth month after the intervention,the clinical data of the two groups were collected.Data were collected and analyzed by IBMSPSS19.0 statistical software.At the same time,the two groups of clinical data were compared.Result:Before the study of intervention,there was no significant difference in the baseline data such as sex,weight and ACT score and MARS-A score between the two groups(P> 0.05).The main study objective: In the first month and third month after the intervention,the MARSA score was higher than basic data,and the proportion of patients with good compliance(MARS-A > 45 indication compliance)increased,but there were no significant(p>0.05).in the sixth month after the intervention,Theproportion of patients with good compliance in the experimental group was significantly higher than that in the control group(p<0.05).The Secondary study objective: In the first month after the intervention,the median of ACT score of the two groups was higher than basic data,and the control of asthma symptoms was improved,but there was no significant;In the third month and sixth month after the intervention,The median score of ACT in the experimental group was significantly higher than that in the control group(p<0.05));When Compared with the basic data(V1vsV0 、 V2vsV0),the median of ACT score in the experimental group and the control group increased obviously.There were significantly difference in the two groups(P<0.05).There was a comparison of quality of life between the groups in the third month and sixth month;There was no significant difference in The median score of the total Mini-AQLQ,asthma symptoms,asthmatic activity limitation,and asthma psychology in the two groups(P>0.05).V2vsV0,V3vsV0,the median score of quality of life in the experimental group and the control group was higher than that in the baseline(P<0.05).In the third month,there was not a significant difference in the asthma psychology between the control group and the experimental group compared with the baseline.However,in the sixth month,the score of the asthma psychology in the experimental group was significantly higher than the baseline or the V2(P<0.05).V2 VS V3,the experimental group had a significant change in the median score of the asthma psychology(P<0.05)and environmental stimulus response of asthma(P<0.05).In contrast,there was not a significant difference in the control group(P>0.05).pulmonary function: Before the intervention,there was no statistical significance in the PEF and Fev1%pred in the two groups(P>0.05).in the sixth month after the intervention,We confirmed a significant difference in the PEF between the two groups(P<0.05).However,wo did not confirm the same result in the FEV1%pred between the two groups.In intra-group comparison(V0vsV3),the changes of PEF in the experimental group were significant(P<0.05).By contrary,There was not a significant diference in the control group with P value more than 0.05;Meanwhile,we did not find a significant change in The Fev1%pred before and after intervention(P>0.05).In the sixth month,there was not a significant difference between the two groups(P>0.05);V0 VS V3,the Fe-NO in the experimental groupand the control group was significantly lower than the baseline(P<0.05).There was 1patient in the experimental group of the total patients because of intravenous infusion of anti osteoporosis drugs visited emergency room.Conclusion:1.With the help of asthma management APP based on smartphone,compared with the traditional group,patients in the Experimental group could have better drug compliance.2.With the help of asthma management APP based on smartphone,Compared with the traditional group,the patients in the experimental group could have better symptom control.3.With the help of asthma management APP based on smartphone,It could help the patients in the experimental to improve their Peak Expiratory Flow.